75.87
price down icon0.75%   -0.57
pre-market  プレマーケット:  75.86   -0.01   -0.01%
loading
前日終値:
$76.44
開ける:
$76.62
24時間の取引高:
5.35M
Relative Volume:
1.41
時価総額:
$44.03B
収益:
$6.07B
当期純損益:
$1.06B
株価収益率:
40.95
EPS:
1.8527
ネットキャッシュフロー:
$799.60M
1週間 パフォーマンス:
-3.61%
1か月 パフォーマンス:
-9.51%
6か月 パフォーマンス:
-2.33%
1年 パフォーマンス:
-0.17%
1日の値動き範囲:
Value
$75.51
$77.56
1週間の範囲:
Value
$74.66
$79.91
52週間の値動き範囲:
Value
$65.94
$87.89

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
名前
Edwards Lifesciences Corp
Name
セクター
Healthcare (1109)
Name
電話
(949) 250-2500
Name
住所
ONE EDWARDS WAY, IRVINE, CA
Name
職員
15,800
Name
Twitter
@edwardslifesci
Name
次回の収益日
2026-02-10
Name
最新のSEC提出書
Name
EW's Discussions on Twitter

Compare EW vs ABT, SYK, MDT, BSX

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
EW
Edwards Lifesciences Corp
75.87 44.36B 6.07B 1.06B 799.60M 1.8527
Medical Devices icon
ABT
Abbott Laboratories
112.68 193.83B 44.33B 6.48B 6.92B 3.7033
Medical Devices icon
SYK
Stryker Corp
366.05 140.01B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
99.49 129.33B 34.76B 4.79B 5.21B 3.7017
Medical Devices icon
BSX
Boston Scientific Corp
74.73 109.92B 20.08B 2.89B 3.82B 1.9391

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-09 アップグレード TD Cowen Hold → Buy
2025-12-18 アップグレード JP Morgan Neutral → Overweight
2025-11-03 アップグレード Raymond James Mkt Perform → Outperform
2025-10-29 アップグレード Jefferies Hold → Buy
2025-10-29 アップグレード Wolfe Research Underperform → Peer Perform
2025-10-08 ダウングレード Oppenheimer Outperform → Perform
2025-10-07 アップグレード Evercore ISI In-line → Outperform
2025-07-29 アップグレード BTIG Research Neutral → Buy
2025-04-24 アップグレード Piper Sandler Neutral → Overweight
2025-01-30 アップグレード Stifel Hold → Buy
2025-01-16 ダウングレード Wolfe Research Peer Perform → Underperform
2024-12-16 アップグレード BofA Securities Neutral → Buy
2024-10-11 再開されました Morgan Stanley Equal-Weight
2024-09-18 ダウングレード Jefferies Buy → Hold
2024-07-31 アップグレード Daiwa Securities Neutral → Outperform
2024-07-29 アップグレード Wolfe Research Underperform → Peer Perform
2024-07-25 ダウングレード BofA Securities Buy → Neutral
2024-07-25 ダウングレード JP Morgan Overweight → Neutral
2024-07-25 ダウングレード Robert W. Baird Outperform → Neutral
2024-07-25 ダウングレード TD Cowen Buy → Hold
2024-07-25 ダウングレード Truist Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-05-22 アップグレード Citigroup Neutral → Buy
2024-05-14 アップグレード Deutsche Bank Hold → Buy
2024-03-07 アップグレード BofA Securities Neutral → Buy
2024-02-02 アップグレード Wells Fargo Equal Weight → Overweight
2024-01-04 ダウングレード Evercore ISI Outperform → In-line
2023-12-11 ダウングレード Citigroup Buy → Neutral
2023-11-28 ダウングレード Wolfe Research Peer Perform → Underperform
2023-09-26 アップグレード Oppenheimer Perform → Outperform
2023-07-19 開始されました Robert W. Baird Outperform
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Neutral
2023-03-08 ダウングレード Wells Fargo Overweight → Equal Weight
2023-02-06 ダウングレード Raymond James Outperform → Mkt Perform
2023-01-31 ダウングレード Bernstein Outperform → Underperform
2023-01-30 ダウングレード Piper Sandler Overweight → Neutral
2022-12-06 ダウングレード Stifel Buy → Hold
2022-10-28 ダウングレード Oppenheimer Outperform → Perform
2022-10-26 開始されました Mizuho Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-29 ダウングレード Canaccord Genuity Buy → Hold
2022-04-13 開始されました Truist Buy
2022-04-06 開始されました Wolfe Research Outperform
2022-03-16 アップグレード Bernstein Mkt Perform → Outperform
2022-03-02 再開されました BofA Securities Neutral
2022-02-02 アップグレード UBS Neutral → Buy
2022-01-27 繰り返されました Citigroup Buy
2022-01-27 繰り返されました Evercore ISI Outperform
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました Stifel Buy
2022-01-27 繰り返されました UBS Neutral
2021-12-17 アップグレード JP Morgan Neutral → Overweight
2021-12-15 アップグレード Citigroup Neutral → Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-12-06 アップグレード Wells Fargo Equal Weight → Overweight
2021-07-30 繰り返されました Canaccord Genuity Buy
2021-07-30 繰り返されました Deutsche Bank Hold
2021-07-30 繰り返されました Jefferies Buy
2021-07-30 繰り返されました Morgan Stanley Overweight
2021-07-30 繰り返されました Oppenheimer Outperform
2021-07-30 繰り返されました Stifel Buy
2021-07-30 繰り返されました UBS Neutral
2021-07-30 繰り返されました Wells Fargo Equal Weight
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-04-05 アップグレード Evercore ISI In-line → Outperform
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-12-11 繰り返されました Canaccord Genuity Buy
2020-09-11 開始されました Wolfe Research Underperform
2020-04-28 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 アップグレード SVB Leerink Mkt Perform → Outperform
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-10 開始されました Oppenheimer Outperform
2020-01-02 ダウングレード Evercore ISI Outperform → In-line
2019-10-24 繰り返されました Canaccord Genuity Buy
2019-09-23 開始されました Piper Jaffray Overweight
2019-07-24 繰り返されました BofA/Merrill Buy
2019-03-18 繰り返されました Canaccord Genuity Buy
2019-01-18 アップグレード BofA/Merrill Neutral → Buy
2019-01-03 開始されました Deutsche Bank Hold
2018-11-28 開始されました UBS Neutral
2018-10-16 開始されました Barclays Underweight
2018-10-02 ダウングレード BofA/Merrill Buy → Neutral
2018-10-02 ダウングレード Guggenheim Buy → Neutral
すべてを表示

Edwards Lifesciences Corp (EW) 最新ニュース

pulisher
04:00 AM

Pulmonary Artery Catheter Market Size to Reach USD 1.97 Billion by 2035 Caused by the Surging Critical Care Procedures Globally - GlobeNewswire Inc.

04:00 AM
pulisher
03:38 AM

Edwards Lifesciences advances smart surgery monitoring with completed SMART TRENDS study - MSN

03:38 AM
pulisher
Feb 16, 2026

Edwards Lifesciences (NYSE:EW) Shows Institutional Concentration Trends Within The S&P 500 Today - Kalkine Media

Feb 16, 2026
pulisher
Feb 16, 2026

Edwards Lifesciences Corporation (NYSE:EW) is a favorite amongst institutional investors who own 88% - Yahoo Finance

Feb 16, 2026
pulisher
Feb 16, 2026

Tobam Has $5.22 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat

Feb 16, 2026
pulisher
Feb 16, 2026

EU Closes Antitrust Investigation Against US' Edwards Lifesciences - marketscreener.com

Feb 16, 2026
pulisher
Feb 16, 2026

Edwards Lifesciences scraps anti-copycat policy, EU drops antitrust investigation - Reuters

Feb 16, 2026
pulisher
Feb 16, 2026

Eu antitrust regulators close investigation into edwards lifesciences after company withdraws anti-copycat policy - marketscreener.com

Feb 16, 2026
pulisher
Feb 16, 2026

Achy Breaky Heart: The FTC Blocks Edwards-JenaValve Aortic Device Deal - marketscreener.com

Feb 16, 2026
pulisher
Feb 15, 2026

What’s the outlook for Edwards Lifesciences Corporation’s sectorQuarterly Growth Report & Fast Moving Stock Watchlists - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Edwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update - Finviz

Feb 15, 2026
pulisher
Feb 15, 2026

Envestnet Asset Management Inc. Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat

Feb 15, 2026
pulisher
Feb 13, 2026

Edwards Lifesciences completes key study on SAPIEN XT THV - MSN

Feb 13, 2026
pulisher
Feb 13, 2026

Is Edwards Lifesciences Corporation stock a smart retirement pickPortfolio Value Summary & Free Accurate Trade Setup Notifications - mfd.ru

Feb 13, 2026
pulisher
Feb 13, 2026

Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day - The AI Journal

Feb 13, 2026
pulisher
Feb 13, 2026

Rhumbline Advisers Acquires 15,792 Shares of Edwards Lifesciences Corporation $EW - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

Edwards Lifesciences Corporation (NYSE:EW) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Feb 13, 2026
pulisher
Feb 12, 2026

How Investors Are Reacting To Edwards Lifesciences (EW) 2026 Guidance After Profit Squeeze In 2025 - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

Halper Sadeh LLC Encourages Edwards Lifesciences - GlobeNewswire

Feb 12, 2026
pulisher
Feb 12, 2026

Edwards Lifesciences Corporation $EW Shares Bought by Oppenheimer Asset Management Inc. - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Wells Fargo Raises Price Target for Edwards Lifesciences (EW) | - GuruFocus

Feb 12, 2026
pulisher
Feb 11, 2026

Edwards Lifesciences Leans Into Growth After Strong Quarter - TipRanks

Feb 11, 2026
pulisher
Feb 11, 2026

Edwards Lifesciences (EW): Truist Securities Maintains Hold Rati - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Edwards Lifesciences (EW) Analyst Ratings Update: Price Target L - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Edwards Lifesciences (NYSE:EW) Advances Structural Heart Solutions - Kalkine Media

Feb 11, 2026
pulisher
Feb 11, 2026

Edwards Lifesciences Corp (NYSE:EW) Issues Upbeat Guidance - FXDailyReport.Com

Feb 11, 2026
pulisher
Feb 11, 2026

Rothschild & Co Redburn Adjusts Edwards Lifesciences PT to $94 From $93, Maintains Buy Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Edwards Lifesciences 2026 Growth Targets Achievable, RBC Says - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Piper Sandler Raises Price Target for Edwards Lifesciences (EW) to $100 | EW Stock News - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Edwards focuses on earlier TAVR adoption - MedTech Dive

Feb 11, 2026
pulisher
Feb 11, 2026

Stifel reiterates Buy rating on Edwards Lifesciences stock at $110 target - Investing.com

Feb 11, 2026
pulisher
Feb 11, 2026

Wells Fargo Raises Price Target for Edwards Lifesciences (EW) | EW Stock News - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Truist Securities Adjusts Price Target on Edwards Lifesciences to $89 From $92, Maintains Hold Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Wells Fargo & Company Raises Edwards Lifesciences (NYSE:EW) Price Target to $100.00 - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Edwards Lifesciences Corporation (NYSE:EW) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 11, 2026
pulisher
Feb 11, 2026

Wells Fargo Adjusts Price Target on Edwards Lifesciences to $100 From $96, Maintains Overweight Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Leerink Partners Adjusts Price Target on Edwards Lifesciences to $87 From $88, Maintains Market Perform Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Baird Adjusts Price Target on Edwards Lifesciences to $87 From $90, Maintains Neutral Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $95 From $108, Maintains Buy Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

The Analyst Verdict: Edwards Lifesciences In The Eyes Of 21 Experts - Benzinga

Feb 11, 2026
pulisher
Feb 11, 2026

BTIG Reiterates Buy Rating for Edwards Lifesciences (EW) | EW St - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Why The Narrative Around Edwards Lifesciences EW Is Shifting After 2026 Outlook And JenaValve Setback - Yahoo Finance

Feb 11, 2026
pulisher
Feb 11, 2026

Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Strategic Investments - GuruFocus

Feb 11, 2026
pulisher
Feb 10, 2026

Edwards Lifesciences Q4 Earnings Call Highlights - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

Edwards Lifesciences earnings missed by $0.04, revenue topped estimates - Investing.com

Feb 10, 2026
pulisher
Feb 10, 2026

Edwards Lifesciences (EW) Earnings Transcript - The Globe and Mail

Feb 10, 2026
pulisher
Feb 10, 2026

Edwards Lifesciences misses EPS estimate by $0.04, surpasses revenue prediction - massdevice.com

Feb 10, 2026
pulisher
Feb 10, 2026

Edwards Lifesciences (NYSE:EW) Sees S&P 500 Trading Uptick, Guidance - Kalkine Media

Feb 10, 2026
pulisher
Feb 10, 2026

Earnings call transcript: Edwards Lifesciences Q4 2025 misses EPS forecast By Investing.com - Investing.com Nigeria

Feb 10, 2026
pulisher
Feb 10, 2026

Edwards Lifesciences (NYSE:EW) Updates Q1 2026 Earnings Guidance - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Earnings call transcript: Edwards Lifesciences Q4 2025 misses EPS forecast - Investing.com

Feb 10, 2026

Edwards Lifesciences Corp (EW) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$80.34
price up icon 2.15%
medical_devices PHG
$31.25
price down icon 0.51%
$70.02
price up icon 7.59%
medical_devices STE
$248.35
price up icon 1.69%
medical_devices ZBH
$96.45
price up icon 1.33%
大文字化:     |  ボリューム (24 時間):